Komal Jhaveri, MD, clinical director for early drug development service at Memorial Sloan Kettering Cancer Center, and Saba Shaikh, MD, breast medical oncologist at Mays Cancer Center at UT Health San Antonio, discuss the DESTINY-Breast08 trial.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: DESTINY-Breast08
Connect with thousands of basic and translational scientists, multidisciplinary clinicians, regulatory and pharmaceutical partners, survivors, and patient advocates at the 49th annual San Antonio Breast Cancer Symposium. Complete your registration by Friday, September 25, to take advantage of discounted early registration rates.
Share: